Drug recall · June 25, 2014
Foradil Aerolizer recall
Why: Failed Stability Specification; out of specification result for particle size distribution during stability testing
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Foradil Aerolizer (formoterol fumarate inhalation powder), 12 mcg per capsule, 60 Capsules, Rx only, Manufactured for: Merck, Sharpe & Dohne Corp., a subsidiary of Merck & Co., Inc. Whitehouse Station, NJ 08889, Manufactured by: Novartis Pharma AG Basle, Switzerland NDC 0085-1401-01
- Lots / codes
Lot F0067 exp. 06/14, F0079 exp. 04/15
- Quantity
- Lot F0067: 45,834 units; Lot F0079: 63,321 units
- Company
- Novartis Pharmaceuticals Corp., Suffern, NY
- Distribution
- Nationwide
- Initiated
- May 28, 2014 · Voluntary: Firm initiated
- Classified
- June 17, 2014
- Reported
- June 25, 2014
- Ended
- February 12, 2015
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Formoterol
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.